1642 related articles for article (PubMed ID: 9461044)
1. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
[TBL] [Abstract][Full Text] [Related]
2. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
4. [Reducing perinatal transmission by antiretroviral therapy].
Schmied B
Wien Med Wochenschr; 1998; 148(23-24):550-5. PubMed ID: 10189685
[TBL] [Abstract][Full Text] [Related]
5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
6. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
7. US Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States, February 25, 2000.
United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group
HIV Clin Trials; 2000; 1(2):39-64. PubMed ID: 11590498
[No Abstract] [Full Text] [Related]
8. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
MMWR Recomm Rep; 1994 Aug; 43(RR-11):1-20. PubMed ID: 7913986
[TBL] [Abstract][Full Text] [Related]
9. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).
United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group Members
HIV Clin Trials; 2001; 2(1):56-91. PubMed ID: 11590515
[No Abstract] [Full Text] [Related]
10. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
11. [Recommendations on the use of antiretroviral agents in pregnant women infected with HIV-1].
Rev Panam Salud Publica; 2001 May; 9(5):345-54. PubMed ID: 11476024
[TBL] [Abstract][Full Text] [Related]
12. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges.
Shannon M
J Perinat Neonatal Nurs; 2002 Sep; 16(2):1-25. PubMed ID: 12233942
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
18. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
[TBL] [Abstract][Full Text] [Related]
19. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
20. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
